Bioasis Technologies Inc. (BIOAF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Sep 28, 2026
Bioasis Technologies Market Cap
Bioasis Technologies has a market cap or net worth of $7.94 thousand as of September 30, 2026. Its market cap has decreased by -50.00% in one year.
Market Cap
7.94K
Enterprise Value
n/a
Revenue
199.01K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since May 4, 2012, Bioasis Technologies's market cap has decreased from 48.79M to 7.94K, a decrease of -99.98%. That is a compound annual growth rate of -45.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 7.94K | - |
| Dec 31, 2024 | 7.94K | -97.87% |
| Dec 29, 2023 | 373.25K | -89.60% |
| Dec 30, 2022 | 3.59M | -76.54% |
| Dec 31, 2021 | 15.30M | -14.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Trevena | 10.74K |
| Syros Pharmaceuticals | 10.73K |
| GeneLink | 10.60K |
| Navidea Biopharmaceuticals | 10.00K |
| 0913693 B.C. | 7.36K |
| Statera Biopharma | 7.26K |
| IO Biotech | 7.20K |
| Therapeutic Solutions International | 7.05K |